Cancer Diagnosis and Prognosis
Published by International Institute of Anticancer Research
eISSN : 2732-7787
Abbreviation : Cancer Diagn. Progn.
Aims & Scope
CANCER DIAGNOSIS & PROGNOSIS (CDP) is an international online open-access bimonthly journal designed to bring together original high-quality works and reviews on experimental and clinical research advancing knowledge on the diagnosis and prognosis of all types of human cancer, leukemia, and metastasis.
CDP is aiming at improving prompt disease management and quality of life of cancer patients through a precise early diagnosis and prognosis.
The topics of CDP include 1.
Experimental development of new diagnostic and prognostic biomarkers; 2.
Clinical application of new biomarkers; 3.
Evaluation of combinations of past and emerging biomarkers; 4.
Molecular pathology and proteomics in the discovery of new biomarkers and systemic cancer staging; 5.
Genetic, epigenetic, and chromosomal markers; 6.
Use of biomarkers in the selection of the proper cancer management; 7.
Use of biomarkers in assessing response, restaging, and prognosis after surgery, radiotherapy, chemotherapy, and/or immunotherapy; 8.
Use of diagnostic procedures including combinations of biomarkers and imaging in the selection and assessment of the proper cancer management; 9.
Novel surgery technologies in improving diagnosis and prognosis.
Each submitted article should include a concrete conclusion constituting a “new piece of knowledge†backed by scientific evidence.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.430 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
h-index
Year | Value |
---|---|
2024 | 11 |
Journal Rank
Year | Value |
---|---|
2024 | 13118 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 399 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.